Why the study?
Pericardial tamponade can be a life-threatening complication of neoplastic disease, and not all lung cancers involve the pericardium in the same way.
Highlights the importance of ruling out malignancy, such as lung adenocarcinoma, in patients presenting with unexplained pericardial tamponade.
Malignancy evaluation warranted in tamponade with cancer history; case report leaves open prospective confirmation.
Pericardial effusion is the accumulation of fluid between the layers of the pericardium. I massive, pericardial tamponade and compression of the myocardium are life threatening conditions. The causes of pericardial effusion are varied, from idiopathic, neoplasms, iatrogenesis, and autoimmune. Pericardial tamponade can be a complication of neoplastic disease. Malignancy must be ruled out in every cardiac tamponade. Malignant etiology must be considered in patients with previous history of malignancy, pericarditis that does not respond to anti-inflammatory treatment, pericardial effusion that increases its amount rapidly, or recurrent pericardial effusion. Metastatic pericardial effusion due to lung cancer is not rare but not all lung cancers involve the same way the pericardium. In this paper, we present the case of a previously healthy patient with pericardial tamponade as presentation form of a lung adenocarcinoma and review the literature.
No takes yet. Share an insight, caveat, or question.
Lozano-Díez et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: